ONL Therapeutics to Highlight New Data in Upcoming Scientific Presentations at the 46th Annual Macula Society Meeting and the XXVth Biennial Meeting of the International Society for Eye Research
January 26, 2023 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Jan. 26, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Percept Corporation Names Vision Industry Leader Jim McGrann as President and Chief Operating Officer
January 16, 2023 07:30 ET
|
Percept
LAS VEGAS, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Percept Corporation, a developer of eye tracking, eye control, and perceptual optimization technology for the global vision industry, is pleased to...
RetinalGeniX Technologies, Inc. to Present at the Emerging Growth Conference Wednesday, October 26, 2022
October 24, 2022 13:05 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies, Inc. OTCQB: RTGN to Present at the Emerging Growth Conference. RetinalGeniX Technologies, Inc. (RTGN) is pleased to...
Orange County Vision Center Announces Grand Opening of New Location
October 11, 2022 09:22 ET
|
Orange County Vision Center
GARDEN GROVE, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Orange County Vision Center is excited to announce the grand opening of a new location in Garden Grove, CA! The new office is spacious and...
Vision Care Market Size Worth USD 237 Billion by 2030 at 4.03% CAGR - Report by Market Research Future (MRFR)
August 11, 2022 04:30 ET
|
Market Research Future
New York, USA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Vision Care Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Vision Care Market Information By...
Vinay Mehindru, MD, MBA Appointed to RetinalGenix Technologies Inc. Board of Directors
July 26, 2022 06:15 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- RetinalGenix™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), announced today the appointment of Vinay Mehindru, MD, MBA to the...
CloudMD Finalizes Review and Settlement of the VisionPros Acquisition
July 22, 2022 07:30 ET
|
CloudMD Software & Services Inc.
VANCOUVER, British Columbia, July 22, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology...
RetinalGeniX Technologies, Inc. Acquires DNA/GPS Inc.
July 06, 2022 08:00 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the acquisition of DNA/GPS Inc.,...
Working From Home? Increased Screen Time Can Cause Dry Eyes
February 22, 2022 09:00 ET
|
Manhattan Lasik Center
NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- With work from home becoming the "new normal," people have started to spend more time in front of screens. Looking at a bright screen for hours, often...
ONL Therapeutics Closes 2nd Tranche of $46.9 Million Series B Financing Upon Achieving ONL1204 Development Milestones
January 13, 2022 07:00 ET
|
ONL Therapeutics
– Lead candidate ONL1204 Ophthalmic Solution has advanced into chronic indications of open-angle glaucoma (OAG) and geographic atrophy (GA) associated with age-related macular degeneration (AMD) – –...